Healthcare Law Blog
JANUARY 31, 2023
A continued expansion of the psychedelic market in healthcare is expected in 2023 and the market worth of companies operating in this space is anticipated to be over $8 billion by 2028. [vi] Part 2, which governs the medical records of federally assisted substance use treatment programs. In December 2022, the U.S.
HIT Consultant
AUGUST 15, 2022
Approximately 42% of Medicare beneficiaries are enrolled in Medicare Advantage plans—a segment projected to reach 46% by 2025. Due to rapid growth of the 65-and-older portion of the population, Medicare expenditures are forecast to reach $1,559.4 billion in 2028, with spending per enrollee reaching $20,751.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hall Render
JANUARY 24, 2022
CMS predicts that home health expenditures will reach $201B by 2028, a 73% increase from 2020. Home health demand is driven by limited hospital resources, growth in telehealth and changes in Medicare policy per HealthPayerIntelligence.
Healthcare IT Today
SEPTEMBER 12, 2023
A major justification for President Biden’s tax hike proposal is to shore up the tenuous finances of Medicare whose trust fund is forecasted to be depleted by 2028. Historically, it is the most prolific driver of family bankruptcy, and now it is on its way to bankrupting our country collectively.
Health Populi
MARCH 26, 2020
health care spending will grow to 20% of the national economy by 2028, forecasted in projections pre-published in the April 2020 issue of Health Affairs, National Health Expenditure (NHE) Projections. trillion in 2028. All bets are off on what the 2028 numbers show. trillion forecasted for 2028? NHE will grow 5.4%
Healthcare Law Blog
JANUARY 5, 2023
Just in time for the holidays, the Centers for Medicare and Medicaid Services (“CMS”) issued the Contract Year 2024 Proposed Rule for Medicare Advantage organizations (“MAOs”) and Part D sponsors (the “Proposed Rule”). Health Equity in Medicare Advantage. Part D Medication Therapy Management Program.
Kaiser Health News
AUGUST 12, 2022
First, it would give the federal government the ability to negotiate prices of some drugs purchased by Medicare beneficiaries, a tool that has long been opposed by the drug industry. The drug pricing provision, estimated to save the government nearly $100 billion over 10 years, would require the U.S. “It’s historic.
Expert insights. Personalized for you.
105 
Let's personalize your content